ResMed Inc.
RMD
$208.05
-$0.93-0.45%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.23% | 13.92% | 11.94% | 29.93% | 21.48% |
| Total Depreciation and Amortization | 37.14% | 13.01% | 8.50% | 41.58% | -4.67% |
| Total Amortization of Deferred Charges | 2.67% | -0.16% | -0.91% | -6.24% | -7.34% |
| Total Other Non-Cash Items | 19.62% | 17.92% | 30.13% | -27.73% | 383.90% |
| Change in Net Operating Assets | -61.32% | -23.85% | 142.52% | 2.86% | 224.10% |
| Cash from Operations | -4.24% | 10.08% | 40.48% | 22.42% | 43.93% |
| Capital Expenditure | -61.83% | -38.24% | -140.84% | -22.93% | 1.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -603.55% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 104.63% | -45.68% | -145.49% | 1,935.84% | -23.73% |
| Cash from Investing | -82.56% | -38.84% | -2,550.05% | -187.50% | 4.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00% | -- | 98.33% | 100.00% |
| Issuance of Common Stock | -17.69% | 9.97% | -2.12% | 8.89% | 84.44% |
| Repurchase of Common Stock | -132.70% | -112.95% | -199.10% | -99.50% | -49.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -12.27% | -12.73% | -12.66% | -9.97% | -10.23% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.16% | -75.11% | -52.75% | 58.33% | 57.11% |
| Foreign Exchange rate Adjustments | -67.58% | 109.60% | -100.64% | 27,475.97% | 250.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.73% | -65.24% | -7.24% | 61,261.20% | 1,384.90% |